|● 2012 Project Initiatives|
|● Ongoing work|
|● 2012 Sponsorship Options - How you can get involved|
|● View/download printable 2012 Sponsorship Program (pdf)|
|● Policy (2012) on receiving financial support from the Pharmaceutical Industry and Medically-Related Products Industry (pdf)|
The Canadian Consortium for the Investigation of Cannabinoids (CCIC) is a federally registered Canadian nonprofit organization of basic and clinical researchers and health care professionals established to promote evidence-based research and education concerning the endocannabinoid system and therapeutic applications of endocannabinoid and cannabinoid agents. On behalf of its Members, the Consortium will:
2011 has been another successful year so far for the CCIC! With the hard work of our Board and Staff, and with the generous support of our sponsors, we have been able to achieve the following milestones:
More education and research, greater networking, and deeper outreach are essential building blocks towards continued success. In this regard, the CCIC looks to our sponsors to help support further research and educational activities for the benefit of both parties and for the patients who ultimately are the target of all our work.
The CCIC’s mission is achieved by means of vital partnerships with our Sponsors. The CCIC is funded through both restricted and unrestricted sponsorship and grants from various stakeholders both in the private and public sectors. Financial support from our sponsors allows the CCIC to undertake initiatives and reach goals set out by the organization. In that regard, the CCIC has several exciting projects underway for 2012 and has designed a Sponsorship/Grant Program that will allow your organization to benefit from its involvement.
The CCIC follows Canadian Rx&D guidelines and subscribes to the CMA Code of Conduct for interactions with the pharmaceutical industry. Our policies are available on our website. The CCIC will not endorse any single product.
|SUMMARY REVIEW OF 2011 ACCOMPLISHMENTS|
The CCIC continues to promote its highly visible national education program series, both in live lecture and online format for healthcare practitioners. The ACE program series is designed to provide a forum to exchange ideas and concerns, to educate and to stimulate interest in cannabinoids as a viable and effective medical option.
In 2011, the CCIC marketed the on-line version of the ACE II and ACE III programs to reach a wider audience.
The CCIC engaged with Bayer Healthcare to organize a series of expert round table discussions in Toronto and Montreal in the spring of 2011 that focused on the clinical evidence of cannabinoids in the treatment of spasticity. These events were designed to raise awareness of the use of medicinal cannabinoids, to review updates in research and clinical trial results, and to discuss how to prescribe cannabinoids for the treatment of spasticity in patients with multiple sclerosis.
The CCIC, in collaboration with the University of Toronto Biomedical Communications department, developed a simulated visual 3D animation of the pathway of cannabinoids from entry to metabolism. This narrated video is a useful cannabinoid education tool and is available for viewing on our ccic.net website.
A very exciting initiative that the CCIC undertook in 2011 was the organization of an accredited clinical symposium at the 2011 Annual Meeting of the International Cannabinoid Research Society (ICRS) in Chicago, Illinois, July 8th 2011.
This half day symposium attracted over 60 scientists, clinicians and industry representatives from around the world. The focus of this event was on current endocannabinoid and cannabinoid research and views on the future of this dynamic field of research and patient care. It included featured talks by internationally renowned cannabinoid experts and was fully accredited by the University California San Francisco (UCSF).
As part of our ongoing mandate to network, the CCIC secured strategic booth presence at the following congresses in 2010:
The CCIC has also been involved in formal presentations to the Colorado State Board of Health and The American Society of Addiction Medicine.
Research is another main theme for the CCIC. In 2011 we made progress on a number of initiatives:
Outreach remains important, and throughout the year the CCIC maintained correspondence with Health Canada, responding to proposed regulatory changes to the Medical Marijuana Access Regulations (MMAR) and the Canadian Medical Association (CMA) regarding its policy on Medical Marijuana; in 2011 we also worked closely with Canadian Health Magazine on patient interest stories. The CCIC continues to liaise with important international and local societies such as the International Association of Cannabinoid Medicine (IACM), the International Cannabinoid Research Society (ICRS), the International Association for the Study of Pain (IASP) and the Quebec Pain Research Network (QPRN).
|CCIC 2012 PROJECT INITIATIVES|
Canada has been an excellent training ground for the CCIC to develop clinical experience with cannabinoids, as well as to develop our cannabinoid research and education experience, but we recognize that educational needs are similar in the USA and Europe where the topic of medical cannabinoids continues to attract interest from the public, health care professionals, policy makers and patients.
Therefore, as we look into 2012, the CCIC’s continued focus is to expand its educational expertise and knowledge to regions outside of Canada where cannabinoid medications are available and where knowledge gaps in cannabinoid education have been identified.
While we will continue to work closely with physicians in Canada with our ACE series programs and other educational initiatives, we have identified other places where health care providers, patients and organizations may benefit from the quality, independent and expert educational programs on cannabinoids and endocannabioids that the CCIC can provide. Sponsorship for any or all program(s) is requested.
The CCIC will host a one-day Official Satellite Symposium of the 14th World Congress on Pain, the biannual meeting of the International Association for the Study of Pain, in Milan, Italy August 25th 2012. This is a full-day symposium focusing on up-to-date cannabinoid research from around the world. It will feature talks by internationally renowned clinical and basic science cannabinoid experts. The symposium will also include a cannabinoid research poster presentation session and an Industry session discussing the latest updates on cannabinoid research.
Working in partnership with our colleagues at the University California San Francisco (UCSF), the CCIC’s next foray into US education will be the organization of an Accredited Clinical Education Program series to run in California in the autumn of 2012.
The program is intended to be an accredited cannabinoid education (ACE) lecture program with open discussion, paid registration, delivered on site at major hospital or clinic locations in cannabinoid relevant locations. The set program will feature 3 expert speakers and will run approximately 3 hours.
The CCIC will secure strategic booth presence at the following congresses:
The CCIC will continue to expand our research activities for 2012. These include:
The CCIC will expand the 2011 series of expert round table discussions for our colleagues in Western Canada.
This unique event will bring together a group of clinical and scientific experts representing various disciplines and all regions of Canada to determine research priorities surrounding the medical use of cannabis.
The objectives of this event will be to:
The CCIC launched a comprehensive new website in 2009 containing research information, data and accredited educational components for all healthcare stakeholders and the general public. CCIC.net is updated regularly and is becoming the definitive portal on cannabinoid research and education.
The CCIC distributes a monthly newsletter to all CCIC sponsors and members. The CCIC newsletter updates all stakeholders, healthcare practitioners and the general public on current news and events, as it pertains to cannabinoid research and education.
|2012 SPONSORSHIP OPTIONS - How you can get involved|
This general funding goes to help support CCIC organizational overhead, networking and outreach. Sponsors will be recognized appropriately on CCIC materials, including website and events.
Project (Target) sponsorship/grants (available only for selected CCIC managed projects) Sponsors will receive recognition based on project sponsored and amount of funding provided. Please contact CCIC to get more information on specifics of funding opportunity.
The following 2012 CCIC programs are available for funding:
Support for achievement and excellence in the field. The following awards are available to fund.
In kind contributions are welcome and recognized by the CCIC. In-kind contributions may include donated equipment, services, other items or facilities necessary to directly implement a project or program that would otherwise have to be purchased if they were not donated by the contributing organization or elicited from other sources. These contributions are specified as other than monetary. Sponsors will be recognized by the CCIC.
This program focuses on developing links between the CCIC and other professional societies that share common goals. Professional societies and similar nonprofit membership organizations can gain access to the CCIC through our Affiliated Partners Program. This includes an exchange of mutually beneficial services, links but no exchange of funds. Partners participating in this program will be recognized by the CCIC.